A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens

This publication has 15 references indexed in Scilit:

• Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment
  Published by Elsevier ,2002
• Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia
  European Journal of Pharmacology, 1994
• (R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability
  Journal of Medicinal Chemistry, 1994
• Cross‐tolerance between delta‐9‐tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212‐2 and anandamide
  British Journal of Pharmacology, 1993
• Development of behavioral tolerance to Δ9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain
  Pharmacology Biochemistry and Behavior, 1993
• Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study
  Brain Research, 1993
• Neuropeptide Y—A cotransmitter with noradrenaline and adenosine 5′-Triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study
  Neuroscience, 1986
• Effects of chronic drug treatment on the sensitivity of mouse vas deferens to drugs
  European Journal of Pharmacology, 1985
• Relative pre- and postjunctional roles of noradrenaline and adenosine 5′-triphosphate as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens
  Neuroscience, 1985
• THE EFFECTS OF 4‐AMINOPYRIDINE ON THE ISOLATED VAS DEFERENS AND ITS EFFECTS ON THE INHIBITORY PROPERTIES OF ADENOSINE, MORPHINE, NORADRENALINE AND γ‐AMINOBUTYRIC ACID
  British Journal of Pharmacology, 1981